Insights from our lab.
Research protocols, compound updates, and science-backed insights from our team.
Dihexa for Long-Haul Cognitive Recovery in Shift Workers
Chronic sleep deprivation destroys synapses. Dihexa and Semax may rebuild them. But no human tria...
Semax for Post-GLP-1 Cognitive Recovery: Restoring BDNF
Semax may restore hippocampal BDNF after long-term oral semaglutide use. This article explains th...
Semax as a Neuroprotective Adjunct to GLP-1 Agonists
Semax may protect the brain from cognitive side effects of GLP-1 agonists and reduce alcohol crav...
Semax and Selank Stack for Alcohol Cravings: A Nootropic Approach to GLP-1 Adjunct Therapy
Semax and Selank are nootropic peptides studied for cognition and anxiety. Could stacking them wi...
Dihexa and the VA’s GLP-1 Alcohol Trial: A Nootropic Adjunct for Cognitive Deficits in Veterans?
Dihexa is a synthetic peptide that may repair brain connections. The VA is testing GLP-1 drugs fo...
Dihexa and the FDA Panel’s Peptide Endorsement: A New Era for Nootropic Legitimacy?
A 2024 FDA panel endorsement of a peptide drug raises questions about the future of nootropic pep...